As the business grows at double-digit rates, representing its interests becomes its own business opportunity
You know that an area of business activity is reaching a certain level of maturity when trade or professional organizations spring up to address the particular needs of that activity. A land-rush sprint is occurring right now as new groups form up to corral the businesses associated with specialty pharmacy. The latest is the Specialty Pharmacy Assn. of America (SPAARx), being launched by Armada Health (Florham Park, NJ), which in turn is self-styled as the “industry's largest specialty-pharmacy group-purchasing and contracting organization.” Armada, which has held a client meeting called the Armada Summit for the past nine years, is essentially converting that event to the first SPAARx meeting. The 2013 Armada Summit is being held in Las Vegas during May 7-10.
Around the same time, a group called the National Assn of Specialty Pharmacy (NASP; Odessa, FL) announced that it would be holding its inaugural meeting in conjunction with the Academy of Managed Care Pharmacy (Alexandria, VA) at the latter’s 2013 Annual Meeting (April 3-5; San Diego; the NASP/AMCP meeting will immediately precede that event). NASP has some cross-management with the founder of the Specialty Pharmacy Journal; its acting executive director is Mike Nameth, former EVP managing Walgreens’ specialty-pharmacy business.
Last year, the Pharmaceutical Care Management Assn. (PCMA; Washington, DC) separated out its Specialty Pharmacy Business Forum from a PBM Summit for the first time; this year, that Forum will be held on March 26-28 in Las Vegas. PCMA is the association of the bigger pharmacy benefit managers (PBMs), most of whom have a specialty subsidiary or division. Then there is the Pharmacy Benefit Management Institute, an individual-member group for benefit managers and healthcare purchasing executives; its 18th Annual Drug Benefit Conference, being held Feb. 18-20 in Las Vegas, will include a specialty-pharmacy component; its program brochure declaims, “The Specialty track was such a huge success last year that we have incorporated two specialty tracks along with a traditional pharmacy benefit track for 2013.”
On the pharmacy professional side of the street, the American Pharmacists Assn. (Washington, DC) has had a Board of Pharmacy Specialties since 1976; the BPS, in turn, has collaborative arrangements with groups like the Hematology/Oncology Pharmacy Assn. (most of today’s specialty pharmacy business is focused on oncology), psychiatric or nuclear pharmacy and some other specialties. Arguably, a “specialty pharmacist” might or might not work at a “specialty pharmacy;” the latter is more an identification of a business structure, rather than the professional training of its staff.
It remains to be seen whether Armada Health will be able to pivot what is essentially a client meeting into an independent organization; the company says that it is in the process of setting up a board of directors and intends for the association to be vendor-neutral. On the other hand, with attendance at its upcoming meeting expected to top 2,500, it is already pulling in many of the participants in the specialty-distribution channel. One thing is for sure—Las Vegas is going to host many pharmacists this spring!
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.